Understanding patient variability to biologic treatments in inflammatory bowel disease.

Al Meslamani, Ahmad Z

Al Meslamani, Ahmad Z.

Affiliation

Al Meslamani AZ; College of Pharmacy, Al Ain University, Abu Dhabi, United Arab Emirates.

Expert Opin Biol Ther ; 24(5): 317-319, 2024 May.

Article in En | MEDLINE | ID: mdl-38785080

Subject(s)

Inflammatory Bowel Diseases; Humans; Inflammatory Bowel Diseases/drug therapy; Inflammatory Bowel Diseases/immunology; Inflammatory Bowel Diseases/therapy; Biological Products/therapeutic use; Biological Products/adverse effects; Biological Therapy

Key words

Biologics; IBD; crohn's disease; patient response; ulcerative colitis

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases Limits: Humans Language: En Journal: Expert Opin Biol Ther Year: 2024 Document type: Article

Fulltext

XML

PubMed Links

Search on Google